31 results on '"Uaesoontrachoon, Kitipong"'
Search Results
2. Mechanism of action and therapeutic route for a muscular dystrophy caused by a genetic defect in lipid metabolism
Catalog
Books, media, physical & digital resources
3. Case study: becoming the first GMP-certified cell and gene therapy manufacturing facility in Thailand
4. Mitochondrial dysfunction and consequences in calpain-3-deficient muscle
5. Cytotoxicity and exhaustion markers of chimeric antigen receptor T cells targeting BCMA in multiple myeloma cell lines between patients and healthy donors.
6. Cytotoxicity and exhaustion markers of chimeric antigen receptor T cells targeting BCMA in multiple myeloma cell lines between patients and healthy donors
7. Comparison of the efficacy of second and third generation lentiviral vector transduced CAR CD19 T cells for use in the treatment of acute lymphoblastic leukemia both in vitro and in vivo models
8. TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy
9. The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouse
10. Osteopontin is linked with AKT, FoxO1, and myostatin in skeletal muscle cells
11. Osteopontin and skeletal muscle myoblasts: Association with muscle regeneration and regulation of myoblast function in vitro
12. Eccentric muscle challenge shows osteopontin polymorphism modulation of muscle damage
13. Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy
14. Biomarker-focused multi-drug combination therapy and repurposing trial in mdx mice
15. The effects of MyD88 deficiency on disease phenotype in dysferlin-deficient A/J mice: role of endogenous TLR ligands
16. Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice
17. Myoblasts Isolated from Hypertrophy-Responsive Callipyge Muscles Show Altered Growth Rates and Increased Resistance to Serum Deprivation-Induced Apoptosis
18. Orthogonal analysis of dystrophin protein and mRNA as a surrogate outcome for drug development
19. Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy
20. Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin‐deficientmdxmice: proof‐of‐concept study and independent validation of efficacy
21. Clarifying The Contradictory Data In The Effect Of Resveratrol In The Mouse Model Of DMD
22. OPN‐a induces muscle inflammation by increasing recruitment and activation of pro‐inflammatory macrophages
23. Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.
24. Elusive sources of variability of dystrophin rescue by exon skipping
25. Omigapil Treatment Decreases Fibrosis and Improves Respiratory Rate in dy2J Mouse Model of Congenital Muscular Dystrophy
26. VBP15, a Glucocorticoid Analogue, Is Effective at Reducing Allergic Lung Inflammation in Mice
27. Effects of Dantrolene Therapy on Disease Phenotype in Dystrophin Deficient mdx Mice
28. Osteopontin deficiency delays inflammatory infiltration and the onset of muscle regeneration in a model of muscle injury
29. Omigapil Treatment Decreases Fibrosis and Improves Respiratory Rate in dy2J Mouse Model of Congenital Muscular Dystrophy.
30. Myoblasts Isolated from Hypertrophy-Responsive Callipyge Muscles Show Altered Growth Rates and Increased Resistance to Serum Deprivation-Induced Apoptosis.
31. Osteopontin deficiency delays inflammatory infiltration and the onset of muscle regeneration in a mouse model of muscle injury
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.